Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES MODEL
4.2 PESTEL ANALYSIS
5 INDUSTRY INSIGHTS: NORTH AMERICA NASAL SPRAY MARKET
5.1 INDUSTRY INSIGHTS
6 REGULATIONS: NORTH AMERICA NASAL SPRAY MARKET
6.1 REGULATORY SCENARIO IN THE U.S.
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASE IN INFECTION AND ALLERGIC CASES
7.1.2 RISING PREVALENCE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND ASTHMA
7.1.3 EFFECTIVENESS OVER OTHER FORMS OF DRUG DELIVERY
7.1.4 IMPROVING PATIENT COMPLIANCE AND ACCEPTABILITY
7.2 RESTRAINTS
7.2.1 PRODUCT RECALLS
7.2.2 ADVERSE EFFECTS OF USING NASAL SPRAYS
7.3 OPPORTUNITIES
7.3.1 NEW RISING DEMAND FOR SELF-ADMINISTRATIVE DRUG DELIVERY
7.3.2 EXPANDING THERAPEUTIC APPLICATIONS FOR NASAL SPRAYS
7.3.3 STRATEGIC INITIATIVES TAKEN BY KEY MARKET PLAYERS
7.4 CHALLENGES
7.4.1 REGULATORY HURDLES
7.4.2 ADDICTION TO NASAL SPRAY
8 NORTH AMERICA NASAL SPRAY MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 DECONGESTION NASAL SPRAY
8.3 STEROID NASAL SPRAY
8.4 SALT WATER SOLUTION/SALINE NASAL SPRAY
8.5 OTHERS
9 NORTH AMERICA NASAL SPRAY MARKET, BY CONTAINER DESIGN
9.1 OVERVIEW
9.2 PUMP BOTTLES
9.3 PRESSURIZED CANISTERS
10 NORTH AMERICA NASAL SPRAY MARKET, BY DOSAGE FORM
10.1 OVERVIEW
10.2 MULTI DOSE
10.3 UNIT/SINGLE DOSE
10.4 BI DOSE
11 NORTH AMERICA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS
11.1 OVERVIEW
11.2 ANTIHISTAMINE
11.3 NASAL STEROIDS
11.4 MAST CELL INHIBITOR
11.5 ANTICHOLINERGIC
12 NORTH AMERICA NASAL SPRAY MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 NASAL CONGESTION
12.3 ALLERGIC AND NON-ALLERGIC RHINITIS
12.4 CENTRAL NERVOUS SYSTEM DISORDERS
12.5 VACCINATION
12.6 OTHERS
13 NORTH AMERICA NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY
13.1 OVERVIEW
13.2 PRESCRIBED
13.3 OVER THE COUNTER
14 NORTH AMERICA NASAL SPRAY MARKET, BY END USER
14.1 OVERVIEW
14.2 HOME CARE SETTINGS
14.3 HOSPITALS
14.4 CLINICS
14.5 COMMUNITY HEALTH CARE
15 NORTH AMERICA NASAL SPRAY MARKET, BY REGION
15.1 NORTH AMERICA
15.1.1 U.S.
15.1.2 CANADA
15.1.3 MEXICO
16 NORTH AMERICA NASAL SPRAY MARKET, COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 GLAXOSMITHKLINE PLC.
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 PFIZER INC.
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 COMPANY SHARE ANALYSIS
18.2.4 PRODUCT PORTFOLIO
18.2.5 RECENT DEVELOPMENTS
18.3 EMERGENT
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENT
18.4 SANDOZ INTERNATIONAL GMBH (A PART OF NOVARTIS)
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 COMPANY SHARE ANALYSIS
18.4.4 PRODUCT PORTFOLIO
18.4.5 RECENT DEVELOPMENT
18.5 CATALENT, INC.
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 COMPANY SHARE ANALYSIS
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPMENTS
18.6 AYTU HEALTH (A SUBSIDIARY OF AYTU BIOPHARMA, INC.)
18.6.1 COMPANY SNAPSHOT
18.6.2 REVENUE ANALYSIS
18.6.3 PRODUCT PORTFOLIO
18.6.4 RECENT DEVELOPMENTS
18.7 AISHWARYA GROUP
18.7.1 COMPANY SNAPSHOT
18.7.2 PRODUCT PORTFOLIO
18.7.3 RECENT DEVELOPMENTS
18.8 ASSERTIO THERAPEUTICS, INC.
18.8.1 COMPANY SNAPSHOT
18.8.2 REVENUE ANALYSIS
18.8.3 PRODUCT PORTFOLIO
18.8.4 RECENT DEVELOPMENT
18.9 AURENA LABORATORIES.
18.9.1 COMPANY SNAPSHOT
18.9.2 PRODUCT PORTFOLIO
18.9.3 RECENT DEVELOPMENTS
18.1 BAYER AG
18.10.1 COMPANY SNAPSHOT
18.10.2 REVENUE ANALYSIS
18.10.3 COMPANY SHARE ANALYSIS
18.10.4 PRODUCT PORTFOLIO
18.10.5 RECENT DEVELOPMENTS
18.11 CIPLA INC.
18.11.1 COMPANY SNAPSHOT
18.11.2 REVENUE ANALYSIS
18.11.3 PRODUCT PORTFOLIO
18.11.4 RECENT DEVELOPMENT
18.12 J PHARMACEUTICALS.
18.12.1 COMPANY SNAPSHOT
18.12.2 PRODUCT PORTFOLIO
18.12.3 RECENT DEVELOPMENTS
18.13 LEEFORD HEALTHCARE LTD
18.13.1 COMPANY SNAPSHOT
18.13.2 PRODUCT PORTFOLIO
18.13.3 RECENT DEVELOPMENTS
18.14 ST. RENATUS.
18.14.1 COMPANY SNAPSHOT
18.14.2 PRODUCT PORTFOLIO
18.14.3 RECENT DEVELOPMENTS
18.15 TEVA PHARMACEUTICALS USA, INC. (A SUBSIDIARY OF TEVA PHARMACEUTICAL INDUSTRIES LTD)
18.15.1 COMPANY SNAPSHOT
18.15.2 REVENUE ANALYSIS
18.15.3 PRODUCT PORTFOLIO
18.15.4 RECENT DEVELOPMENTS
18.16 ULTRATECH INDIA LIMITED
18.16.1 COMPANY SNAPSHOT
18.16.2 PRODUCT PORTFOLIO
18.16.3 RECENT DEVELOPMENTS
18.17 VIATRIS INC.
18.17.1 COMPANY SNAPSHOT
18.17.2 REVENUE ANALYSIS
18.17.3 COMPANY SHARE ANALYSIS
18.17.4 PRODUCT PORTFOLIO
18.17.5 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
List of Table
TABLE 1 NORTH AMERICA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 2 NORTH AMERICA DECONGESTION NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 NORTH AMERICA STEROID NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 4 NORTH AMERICA SALT WATER SOLUTION/SALINE NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 5 NORTH AMERICA OTHERS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 NORTH AMERICA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION)
TABLE 7 NORTH AMERICA PUMP BOTTLES IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 8 NORTH AMERICA PRESSURIZED CANISTERS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 NORTH AMERICA NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION)
TABLE 10 NORTH AMERICA MULTI DOSE IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 11 NORTH AMERICA UNIT/SINGLE DOSE IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 NORTH AMERICA BI DOSE IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 13 NORTH AMERICA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION)
TABLE 14 NORTH AMERICA ANTIHISTAMINE IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 NORTH AMERICA NASAL STEROIDS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 NORTH AMERICA MAST CELL INHIBITOR IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 NORTH AMERICA ANTICHOLINERGIC IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 18 NORTH AMERICA NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 19 NORTH AMERICA NASAL CONGESTION IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 20 NORTH AMERICA ALLERGIC AND NON-ALLERGIC RHINITIS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 NORTH AMERICA CENTRAL NERVOUS SYSTEM DISORDERS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 NORTH AMERICA VACCINATION IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 NORTH AMERICA OTHERS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 24 NORTH AMERICA NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION)
TABLE 25 NORTH AMERICA PRESCRIBED IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 NORTH AMERICA OVER THE COUNTER IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 NORTH AMERICA NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 28 NORTH AMERICA HOME CARE SETTINGS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 NORTH AMERICA HOSPITALS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 NORTH AMERICA CLINICS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 NORTH AMERICA COMMUNITY HEALTH CARE IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 NORTH AMERICA NASAL SPRAY MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 33 NORTH AMERICA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 34 NORTH AMERICA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION)
TABLE 35 NORTH AMERICA NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION)
TABLE 36 NORTH AMERICA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION)
TABLE 37 NORTH AMERICA NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 38 NORTH AMERICA NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION)
TABLE 39 NORTH AMERICA NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 40 U.S. NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 41 U.S. NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION)
TABLE 42 U.S. NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION)
TABLE 43 U.S. NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION)
TABLE 44 U.S. NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 45 U.S. NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION)
TABLE 46 U.S. NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 47 CANADA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 48 CANADA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION)
TABLE 49 CANADA NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION)
TABLE 50 CANADA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION)
TABLE 51 CANADA NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 52 CANADA NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION)
TABLE 53 CANADA NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 54 MEXICO NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 55 MEXICO NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION)
TABLE 56 MEXICO NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION)
TABLE 57 MEXICO NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION)
TABLE 58 MEXICO NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 59 MEXICO NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION)
TABLE 60 MEXICO NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION)
List of Figure
FIGURE 1 NORTH AMERICA NASAL SPRAY MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA NASAL SPRAY MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA NASAL SPRAY MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA NASAL SPRAY MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA NASAL SPRAY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA NASAL SPRAY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA NASAL SPRAY MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA NASAL SPRAY MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 NORTH AMERICA NASAL SPRAY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA NASAL SPRAY MARKET: SEGMENTATION
FIGURE 11 THE INCREASE IN INFECTION AND ALLERGIC CASES IS EXPECTED TO DRIVE THE NORTH AMERICA NASAL SPRAY MARKET IN THE FORECAST PERIOD
FIGURE 12 THE DECONGESTION NASAL SPRAY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA NASAL SPRAY MARKET IN 2023 AND 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA NASAL SPRAY MARKET
FIGURE 14 NORTH AMERICA NASAL SPRAY MARKET: BY PRODUCT TYPE, 2022
FIGURE 15 NORTH AMERICA NASAL SPRAY MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 16 NORTH AMERICA NASAL SPRAY MARKET: BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 17 NORTH AMERICA NASAL SPRAY MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 NORTH AMERICA NASAL SPRAY MARKET: BY CONTAINER DESIGN, 2022
FIGURE 19 NORTH AMERICA NASAL SPRAY MARKET: BY CONTAINER DESIGN, 2023-2030 (USD MILLION)
FIGURE 20 NORTH AMERICA NASAL SPRAY MARKET: BY CONTAINER DESIGN, CAGR (2023-2030)
FIGURE 21 NORTH AMERICA NASAL SPRAY MARKET: BY CONTAINER DESIGN, LIFELINE CURVE
FIGURE 22 NORTH AMERICA NASAL SPRAY MARKET: BY DOSAGE FORM, 2022
FIGURE 23 NORTH AMERICA NASAL SPRAY MARKET: BY DOSAGE FORM, 2023-2030 (USD MILLION)
FIGURE 24 NORTH AMERICA NASAL SPRAY MARKET: BY DOSAGE FORM, CAGR (2023-2030)
FIGURE 25 NORTH AMERICA NASAL SPRAY MARKET: BY DOSAGE FORM, LIFELINE CURVE
FIGURE 26 NORTH AMERICA NASAL SPRAY MARKET: BY THERAPEUTIC CLASS, 2022
FIGURE 27 NORTH AMERICA NASAL SPRAY MARKET: BY THERAPEUTIC CLASS, 2023-2030 (USD MILLION)
FIGURE 28 NORTH AMERICA NASAL SPRAY MARKET: BY THERAPEUTIC CLASS, CAGR (2023-2030)
FIGURE 29 NORTH AMERICA NASAL SPRAY MARKET: BY THERAPEUTIC CLASS, LIFELINE CURVE
FIGURE 30 NORTH AMERICA NASAL SPRAY MARKET: BY APPLICATION, 2022
FIGURE 31 NORTH AMERICA NASAL SPRAY MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 32 NORTH AMERICA NASAL SPRAY MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 33 NORTH AMERICA NASAL SPRAY MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 34 NORTH AMERICA NASAL SPRAY MARKET: BY PRESCRIPTION/AVAILABILITY, 2022
FIGURE 35 NORTH AMERICA NASAL SPRAY MARKET: BY PRESCRIPTION/AVAILABILITY, 2023-2030 (USD MILLION)
FIGURE 36 NORTH AMERICA NASAL SPRAY MARKET: BY PRESCRIPTION/AVAILABILITY, CAGR (2023-2030)
FIGURE 37 NORTH AMERICA NASAL SPRAY MARKET: BY PRESCRIPTION/AVAILABILITY, LIFELINE CURVE
FIGURE 38 NORTH AMERICA NASAL SPRAY MARKET: BY END USER, 2022
FIGURE 39 NORTH AMERICA NASAL SPRAY MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 40 NORTH AMERICA NASAL SPRAY MARKET: BY END USER, CAGR (2023-2030)
FIGURE 41 NORTH AMERICA NASAL SPRAY MARKET: BY END USER, LIFELINE CURVE
FIGURE 42 NORTH AMERICA NASAL SPRAY MARKET: SNAPSHOT (2022)
FIGURE 43 NORTH AMERICA NASAL SPRAY MARKET: BY COUNTRY (2022)
FIGURE 44 NORTH AMERICA NASAL SPRAY MARKET: BY COUNTRY (2023 & 2030)
FIGURE 45 NORTH AMERICA NASAL SPRAY MARKET: BY COUNTRY (2022 & 2030)
FIGURE 46 NORTH AMERICA NASAL SPRAY MARKET: PRODUCT TYPE (2023-2030)
FIGURE 47 NORTH AMERICA NASAL SPRAY MARKET: COMPANY SHARE 2022 (%)
